Medartis Holding AG (SWX:MED)
Switzerland · Delayed Price · Currency is CHF 79.60
-0.80 (-1.00%)
Apr 2, 2026, 10:36 AM CET
Medartis Holding AG Revenue
In the year 2025, Medartis Holding AG had annual revenue of 269.26M CHF with 19.76% growth. Medartis Holding AG had revenue of 146.22M in the half year ending December 31, 2025, with 34.45% growth.
Revenue
269.26M
Revenue Growth
+19.76%
P/S Ratio
3.71
Revenue / Employee
213.87K
Employees
1,337
Market Cap
999.58M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 269.26M | 44.43M | 19.76% |
| Dec 31, 2024 | 224.83M | 12.83M | 6.05% |
| Dec 31, 2023 | 212.01M | 29.18M | 15.96% |
| Dec 31, 2022 | 182.82M | 22.94M | 14.35% |
| Dec 31, 2021 | 159.88M | 32.23M | 25.25% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Roche Holding AG | 63.36B |
| Novartis AG | 44.94B |
| Lonza Group AG | 6.53B |
| Galderma Group AG | 4.16B |
| Aevis Victoria | 955.96M |
| PolyPeptide Group AG | 362.47M |
| SKAN Group AG | 333.34M |
| Basilea Pharmaceutica AG | 232.38M |